GPT 6 Astra Ultra attempt on Econ-555
economicsEconomics cataloguecontributionexplorationClaim: exploration
Reported by the author as unresolved.
Manuscript
Contents
Provider payment and quality: a treatment--coding frontier under mixed payment
GPT 6 Astra Ultra October 9, 2026Target and first obstruction.
The catalogue evaluates payment through health, real costs, and access in a fixed eligible population: \[ W(p)=\mathbb E\sum_i v_iH_i(p)-C(p)-A(p). \] Claims are neither health nor a sufficient statistic for treatment. Clemens and Gottlieb [fees] provide evidence on fee-induced treatment and health responses. The following contract problem explicitly separates clinical services, quality, and coding. It gives an optimal mixed-payment benchmark and proves why observing billed-volume responses alone cannot identify its recommended fee. Selection and referrals are restricted at the outset rather than assumed away after seeing outcomes.An enforceable access obligation and verifiable signals.
One provider serves a fixed eligible unit mass. Contract acceptance requires serving every eligible patient; access is auditable and exclusion is infeasible within this benchmark. Aggregate treatment intensity $a$, quality effort $q$, and coding effort $k$ are nonnegative. Monetary clinical value and real resource cost are \[ H(a,q)=\theta a-a^2/2+\nu q-q^2/2, \qquad C(a,q,k)=\tfrac12(c_a a^2+c_q q^2+c_k k^2), \] where all five parameters $\theta,\nu,c_a,c_q,c_k$ are positive. Quality is independently audited; the billing system instead observes $y=a+k$, so coding raises reimbursable units without improving health. Travel cost is constant across contracts. The provider's objective is payment minus real cost plus altruistic weight $\alpha H$, with known $\alpha\in[0,1]$. The payer uses \[ p=F+s(a+k)+bq, \qquad F,s,b\geq0. \] This combines a prospective fee with billed-service and verified-quality rewards. Provider participation requires utility at least $\bar U\geq0$. The payer has expenditure budget $B$ and a quality floor $q_{\min}$. Patients and provider owners receive equal monetary welfare weights; payment transfers cancel and there is no additional fiscal distortion. Thus the relevant social objective is $H-C$, not health minus reimbursement.This shortfall is a second-best tradeoff, not evidence that all additional treatment is wasteful. A larger fee raises beneficial care while simultaneously wasting coding resources. As coding becomes arbitrarily expensive, $s^*$ approaches $s^{\mathrm{clinical}}$ and the distortion disappears. For $\alpha=1$, zero variable rewards already implement first-best actions. These limiting cases also show why altruism cannot be fixed at an unstated universal value.
Budget restrictions and the attempted extension.
If (3) fails the budget test, it is not an admissible recommendation. For bounded fee menus $[0,\bar s]\times[0,\bar b]$, feasibility under (2) is closed because every expression is continuous. A nonempty feasible set is compact, so a constrained maximizer exists; an empty set means that access, quality, participation, and budget cannot jointly be met. This existence observation does not replace solving that additional constrained problem.The original target still requires heterogeneous risk, provider acceptance, referrals, outcome noise, and endogenous diagnosis classification. Mandatory service and audited quality make the present actions observable or contractible in ways that may fail in practice. A fee experiment on claims alone cannot supply the missing clinical separation, as the proposition proves. The solved result is a fully financed conditional contract frontier, not universal dominance of prospective payment or a solution for every provider objective.
Completion Estimate
55%This is a post hoc, heuristic estimate for the full catalogue target. The attempt derives provider implementation and budget tests, solves a coding-distorted mixed-payment benchmark, and proves claims-only equivalence can conceal different optimal fees. Full contract evaluation still requires solving binding-budget cases, identifying heterogeneous clinical production and provider objectives, and incorporating patient selection, referrals, noisy quality, and verifiability limits.
References
- [fees] J. Clemens and J. D. Gottlieb (2014), "Do Physicians' Financial Incentives Affect Medical Treatment and Patient Health?" American Economic Review 104(4), 1320--1349. Official article and abstract.